9 Symptoms That All Cancer Survivors Should Watch For
Getting through cancer treatment successfully is something to celebrate. To stay in good health, doctors say you need to watch for other symptoms, including vision changes, headaches and problems with balance.
Many cancer survivors don’t realize that 25 percent of people who survive some common cancers go on to develop a brain tumor. These brain tumors don’t originate in the brain but are actually cancerous cells from the original tumor that travel to the brain through the bloodstream. When this happens, doctors call these tumors brain metastases.
When this happens, the resulting growth needs early treatment. Dr. Barnett says early detection can help people get the right treatment at the right time to avoid serious complications. This is why you need to be vigilant and pay attention to your symptoms.
Watch for these 9 signs
If you’ve had cancer and experience these symptoms, be sure to tell your doctor:
- Vision changes, such as double vision or partial vision loss
- Headaches, possibly with nausea
- Numbness or tingling in part of the body
- Paralysis or difficulty moving any part of the body
- Inability to walk
- Difficulty with balance and an increased incidence of falls
- Difficulty speaking, including slurred words or incoherent speech
- Problems with mental acuity, such as not being able to read or tell time
- Seizure or convulsions
Metastatic brain tumors tend to develop gradually, although severe episodes can occur. No matter what, it’s important to tell your doctor immediately so he or she can evaluate you and treat you early as needed.
Treatable brain tumors
For years, doctors believed that brain metastases were uniformly fatal. Treatment could only relieve symptoms. Today, they know that such tumors are treatable, thanks to technological and medical advances. The key is early detection.
To help in this fight, Cleveland Clinic teamed with the Northern Ohio American Cancer Society to establish the B-Aware Program. “Our goal is to educate at-risk cancer patients so that brain metastases are detected as early as possible, when they have the greatest number of treatment options,” Dr. Barnett says.
Many treatments available
We’ve come a long way from the days when the only treatment option available for brain metastases was whole brain radiation. This often failed to control the tumors. Today, aggressive and precisely delivered treatments produce better outcomes with fewer side effects.
Treatment options depend on the location, type and extent of the tumor, and include:
- Radiosurgery. Radiosurgery directs highly focused beams of radiation at the tumor with extreme precision. This will not destroy the tumor, but may succeed in stopping tumor growth. Surgeons deliver this radiation so precisely that they can spare the surrounding brain tissue. Gamma Knife surgery is a common form of radiosurgery.
- Minimal access surgery. This type of surgery allows doctors to remove the tumor in a faster, simpler way. Surgeons make a very small incision in the skull or hidden in a nearby structure. This reduces postoperative complications, minimizes pain and scarring, and shortens recovery time.
- Localized radiotherapy, or radiation therapy. Radiotherapy exposes the cancerous cells to ionizing radiation that injures or destroys them. Doctors often use radiotherapy before or in addition to radiosurgery.
- Medical therapies. Chemotherapy uses drugs to kill tumor cells that are dividing most rapidly. Many drugs used successfully for tumors in the body cannot penetrate into the brain. However, in certain cases, chemotherapy or other medical treatments may secure control of certain brain metastases.
“We want to help patients be aware of all management options, so they don’t blindly agree to a proposed treatment which may not be in their best interest,” Dr. Barnett says. “They always have the right to seek a second opinion.
This article was written by Brain and Spine Team from Cleveland Clinic and was legally licensed through the NewsCred publisher network.
Get more resources and information by selecting a specific cancer type.